Scorpion Capital · research-note
TransMedics (TMDX)
342 pages · 3 arc beats · 0 loops
TransMedics (TMDX)
Scorpion Capital · 2025-01 arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
120406080100120140160180200220240260280300320340342
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 36 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Critique of TransMedics Group Inc. 10 slides 100% 10/10 slides 100% 10/10 slides · 67 hits — 0/10 slides
10% 1/10 slides · 2 hits 60% 6/10 slides 100% 10/10 slides · 19 hits — 0/10 slides
Exposure of Contradictions 19 slides 100% 19/19 slides 100% 19/19 slides · 130 hits — 0/19 slides
5.3% 1/19 slides · 2 hits 57.9% 11/19 slides 100% 19/19 slides · 28 hits — 0/19 slides
Testimonials from Industry Experts 7 slides 100% 7/7 slides 100% 7/7 slides · 29 hits — 0/7 slides
71.4% 5/7 slides 42.9% 3/7 slides 100% 7/7 slides — 0/7 slides
Slide inventory
342 every slide · same image gating as the playbook
01
The slide includes a call to action for stakeholders to contact the firm regarding an upcoming FDA Citizen Petition.front_matter
03
The slide uses anecdotal evidence to frame the company's leadership as a 'villain' figure, specifically highlighting potential legal and regulatory scrutiny.name_villain
Open slide detailBeat · Testimonials from Industry Experts
04
The slide uses quotes to build a narrative of corporate malfeasance and systemic gaming of organ allocation processes.expose_contradiction
Open slide detailBeat · Testimonials from Industry Experts
05
The quote highlights a conflict between administrative credit holds and urgent clinical needs for heart transplants.illustrate_case
Open slide detailBeat · Testimonials from Industry Experts
06
The slide uses a direct quote to expose a contradiction between company claims and user experience.expose_contradiction
Open slide detailBeat · Testimonials from Industry Experts
07
The slide uses a direct quote to frame TransMedics as a failing company due to poor leadership and predatory behavior, drawing an analogy to Blackberry's declinexpose_contradiction
Open slide detailBeat · Testimonials from Industry Experts
08
The slide uses highly aggressive, accusatory language (e.g., 'fraudulent billing racket', 'organ trafficking scheme', 'prostitutes').front_matter
Open slide detailBeat · Testimonials from Industry Experts
11
The slide uses extreme, inflammatory language to attack the subject company and its leadership.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
12
The slide uses a 'Spy The Lie' framework to interpret CEO responses as deceptive.expose_contradiction
Open slide detailBeat · Critique of TransMedics Group Inc.
13
The slide uses aggressive, accusatory language ('fraud', 'hubris', 'one-trick pony') to frame the company negatively.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
14
The slide uses a 'villain' narrative to frame the CEO's actions as potentially criminal, leveraging a recent legal precedent to build credibility.expose_contradiction
Open slide detailBeat · Critique of TransMedics Group Inc.
15
The slide uses a short-selling thesis style, highlighting valuation concerns and legal/regulatory risks in the medical air transport industry.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
16
The slide uses a 'wink-wink' narrative to frame the company's own marketing as evidence of a non-clinical value proposition.expose_contradiction
Open slide detailBeat · Critique of TransMedics Group Inc.
17
The slide uses highly charged, aggressive language to frame the company and its leadership as predatory and unprofessional.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
18
The slide uses direct quotes to build a narrative of customer churn risk, specifically highlighting the threat of switching to OrganOX.expose_contradiction
Open slide detailBeat · Critique of TransMedics Group Inc.
19
The slide uses a combination of narrative summary and a direct Q&A transcript excerpt to substantiate claims of unethical conduct.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
20
The slide uses strong, emotive language ('greedy', 'predatory', 'hate') to frame the company as a villain in the transplant market.name_villain
Open slide detailBeat · Critique of TransMedics Group Inc.
21
The slide uses a combination of narrative analysis and direct testimonial quotes to build a bearish case against the company.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
22
The slide uses aggressive, short-selling style language ('colossal failure', 'crashing and burning', 'one-trick pony').name_villain
Open slide detailBeat · Exposure of Contradictions
23
The slide uses a sarcastic tone to undermine the company's intellectual property claims.name_villain
Open slide detailBeat · Exposure of Contradictions
24
The slide uses a 'villain' framing to attack the company's business model as exploitative of the US healthcare system.name_villain
Open slide detailBeat · Exposure of Contradictions
25
The slide uses a 'villain critique' approach to frame the company's business model as a 'government pay scam'.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
26
Uses direct quotes from industry experts to build a case of systemic exploitation.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
27
The slide uses a combination of investigative journalism style text and corporate marketing materials to expose a perceived conflict of interest.name_villain
Open slide detailBeat · Exposure of Contradictions
28
The slide uses a combination of anecdotal evidence from centers and financial logic to frame the company's business model as fraudulent.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
29
The slide uses a Q&A format to highlight specific allegations from an industry executive regarding OIG, DOJ, and IRS involvement.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
30
The slide uses highlighted text to emphasize key quotes from an industry executive regarding systemic abuse of the cost-based reimbursement model.expose_contradiction
Open slide detailBeat · Exposure of Contradictions
31
The slide uses direct quotes from an industry executive to build a bearish case against TransMedics.expose_contradiction
32
The slide uses a Q&A transcript format to build a narrative about an ongoing investigative report.expose_contradiction
33
The slide uses a Q&A format to highlight potential financial incentives and investigative scrutiny regarding TransMedics.expose_contradiction
34
The slide uses a 'guilt by association' argument, linking TransMedics to a failed company (Nevro) based on demographic patterns in their user base.expose_contradiction
35
The slide uses a narrative approach to cast doubt on the reputation of a prominent surgeon, linking him to high mortality rates and unethical practices.other
36
The slide uses visual evidence from a conference to link corporate figures with potential conflicts of interest and allegations of misconduct.expose_contradiction
37
The slide uses a Q&A format and direct quotes to build a narrative of a toxic, insular culture.expose_contradiction
38
This is a short-seller research note attempting to cast doubt on management integrity via association.expose_contradiction
39
The slide uses visual evidence (event flyer and WhatsApp screenshots) to link a surgeon, a broker, and the company's leadership.expose_contradiction
40
The slide uses a Q&A transcript format to highlight potential regulatory and ethical misconduct.expose_contradiction
42
The slide uses a news headline and a snippet of an official letter to frame a corporate controversy.expose_contradiction
43
The slide presents a narrative of corporate misconduct/extortion based on a letter from a politician.expose_contradiction
44
The slide contains two paragraphs of text that are largely redundant, summarizing the same allegation. The source is a Daily Caller article referencing a letterexpose_contradiction
45
The slide presents a narrative of corporate malfeasance by quoting a letter from a politician and contrasting it with alleged CEO statements.expose_contradiction
46
The slide uses direct quotes from a letter to frame potential corporate misconduct.expose_contradiction
47
The slide uses a narrative framing to highlight the CEO's aggressive denial of competitor-driven allegations.expose_contradiction
48
The slide uses direct quotes from a formal letter to refute claims.preempt_rebuttal
49
Uses direct quotes from an ex-logistics manager to frame the company as a service provider rather than a medical device company.expose_contradiction
50
The slide uses a Q&A format to highlight contradictions between company policy and public statements.expose_contradiction
51
The slide uses a 'Q&A' format to document expert interviews, highlighting the lack of choice for customers.expose_contradiction
52
The slide uses Q&A transcripts to highlight forced reliance on third-party technicians and procurement teams, which the experts view as a significant operationaexpose_contradiction
53
The slide uses a Q&A format to highlight alleged anti-competitive practices and coercive business tactics.expose_contradiction
54
The slide uses Q&A transcript excerpts to build a negative narrative about the company's business practices.name_villain
55
The slide uses direct quotes and Q&A transcripts to build a case of corporate coercion.expose_contradiction
56
The slide uses a 'he said, she said' structure to highlight a potential fraud or misrepresentation by the CEO.expose_contradiction
57
The slide uses a 'he-said, she-said' structure to frame the company's NOP service as a potential antitrust issue.expose_contradiction
58
The slide uses a combination of legal theory and qualitative expert testimony to build a case for anticompetitive behavior.expose_contradiction
59
The slide uses a Q&A format to highlight the discrepancy between pre-approval and post-approval pricing.expose_contradiction
60
The slide uses direct quotes to build a case for anticompetitive behavior, specifically focusing on the forced bundling of procurement services with product usaname_villain
61
The slide uses direct quotes from KOLs to build a case against the company's pricing model.name_villain
62
The slide uses direct quotes from industry experts to frame the company's pricing as predatory and its leadership as arrogant.expose_contradiction
63
Includes direct quotes from a transplant administrator/executive at MGH.expose_contradiction
64
The slide uses direct quotes from MGH staff to argue that TransMedics' business model is built on control rather than efficiency.expose_contradiction
65
The slide uses a Q&A format to highlight alleged anti-competitive behavior (tying/bundling).expose_contradiction
66
The slide uses a Q&A format to present expert testimony as evidence of the company's alleged predatory practices.name_villain
67
The slide uses direct quotes from a transplant surgeon to support the claim of coercive business practices.expose_contradiction
68
The slide uses a Q&A transcript format to build a narrative of extortion.expose_contradiction
69
The slide uses Q&A format to build a narrative of unethical behavior and coercion.name_villain
71
The slide uses a map to visualize the scale of the company's operations, which the author then characterizes as a 'fraudulent billing conspiracy'.expose_contradiction
72
The slide uses a Q&A format to validate the claims of systematic fraud.expose_contradiction
73
The slide uses a Q&A format to present testimony regarding unethical business practices and overbilling.expose_contradiction
74
The slide uses a Q&A format to build a case for fraudulent billing practices.expose_contradiction
75
The slide uses Q&A transcripts to expose a contradiction between operational efficiency and the company's new logistics model.expose_contradiction
76
The slide uses a Q&A format to highlight internal confusion and the visibility of national operations via an internal app.expose_contradiction
77
The slide uses a Q&A format to highlight specific allegations of corporate misconduct.expose_contradiction
78
The slide uses highlighted text blocks to emphasize key quotes from a consultation call transcript.expose_contradiction
79
The slide uses a Q&A format to build credibility and expose operational inefficiencies.expose_contradiction
80
The slide uses a Q&A transcript format to substantiate the claim of system manipulation.expose_contradiction
81
The slide uses a combination of summary text and a direct, highlighted quote from a UCSF administrator to substantiate claims of fraudulent billing.expose_contradiction
82
The slide uses direct quotes from interviews to highlight a lack of oversight and forced vendor usage.expose_contradiction
83
The slide uses a Q&A format to highlight specific instances of alleged fraud, emphasizing the lack of transparency and the financial impact of unnecessary air texpose_contradiction
84
The slide uses a Q&A format to highlight skepticism about TransMedics' billing practices.expose_contradiction
85
The slide presents a Q&A style interview excerpt to support a claim of extortion/fraud.expose_contradiction
86
The slide highlights a specific geographical proximity (San Ramon) to argue that TransMedics' operational choices are inefficient and costly for transplant centexpose_contradiction
87
The slide uses a Q&A format to provide primary source evidence for the claims made in the headline.expose_contradiction
88
The slide uses a Q&A format to build a narrative of 'extortion' and 'wasted organs' against the subject company.name_villain
89
The slide uses a highlight-heavy block quote to emphasize the alleged extortion and fraudulent billing.expose_contradiction
90
The slide uses a testimonial to highlight a shift from a collaborative 'backyard relationship' to a profit-driven 'utilization at all costs' model.expose_contradiction
91
The slide uses a combination of summary text and a direct, highlighted quote to establish a pattern of recidivist behavior by the subject company.name_villain
92
The slide uses a Q&A format to highlight alleged wasteful practices (flying multiple planes) and the need for manual intervention to correct them.expose_contradiction
93
The slide uses a Q&A format to present a customer testimonial, highlighting specific phrases like 'roundabout answers' and 'used car salesman'.expose_contradiction
94
The slide uses direct quotes from industry experts to build a case against the subject company's business practices.expose_contradiction
95
The slide uses a Q&A transcript format to substantiate claims of unnecessary high-cost air travel for short-distance organ procurement.expose_contradiction
96
The slide uses a Q&A format to expose a potential business practice contradiction.expose_contradiction
97
The slide uses a quote to frame a potential conflict of interest or perverse incentive structure in organ transport.expose_contradiction
98
This is a highly inflammatory slide accusing the company of illegal kickbacks and unethical business practices.name_villain
99
This is a short-seller research note slide containing allegations of fraud and unethical business practices.name_villain
100
The slide uses a combination of narrative text and visual evidence (social media posts) to discredit the subject.name_villain
101
The slide uses a skeptical tone to challenge the scientific validity of the claims presented in the video.expose_contradiction
102
The slide uses a 'villain' framing to call out specific medical professionals, linking them to questionable practices and providing visual evidence (conference name_villain
103
The slide uses expert testimony to build a case for high customer concentration and potential ethical/business risks.expose_contradiction
104
The slide uses a Q&A transcript format to highlight defensive behavior from a subject.expose_contradiction
105
The slide uses a Q&A transcript format to present anecdotal evidence of potential unethical business practices.expose_contradiction
106
The slide uses a Q&A format to highlight potential ethical concerns regarding stock ownership and consulting arrangements.expose_contradiction
107
The slide uses Q&A transcripts to build a narrative of 'organ trafficking' or unethical donor selection.expose_contradiction
108
The slide uses expert testimony to cast doubt on the quality of organs used by high-volume TransMedics users.expose_contradiction
110
The slide uses a Q&A format to highlight rumors of a Washington Post investigation into alleged kickbacks.expose_contradiction
111
The slide uses a Q&A format to highlight rumors of financial incentives influencing hospital usage of TransMedics devices.expose_contradiction
112
The slide uses a Q&A format to highlight specific allegations of bribery, kickbacks, and federal/state investigations.expose_contradiction
113
The slide uses a Q&A format to highlight the 'reasonable cost' loophole and the potential for government crackdown.expose_contradiction
114
The slide uses direct quotes from an industry executive to frame TransMedics as a target for regulatory investigation.name_villain
115
The slide uses a Q&A format to highlight a specific industry expert's bearish view on TransMedics.expose_contradiction
117
The slide uses a Q&A format to highlight a specific allegation of regulatory non-compliance.expose_contradiction
118
The slide uses red circles and arrows to annotate screenshots of the CMS Open Payments database to point out irregularities.expose_contradiction
119
The slide uses a Q&A format to build a case of corporate malfeasance or regulatory avoidance.expose_contradiction
120
The slide uses a quote to expose potential unethical vendor practices.expose_contradiction
121
The slide uses a Q&A format to present expert testimony regarding alleged illegal business practices.expose_contradiction
122
The slide uses a Q&A transcript format to substantiate claims of industry-wide corruption and ongoing investigations.expose_contradiction
123
The slide uses a Q&A transcript format to substantiate claims of kickbacks in the organ transport industry.expose_contradiction
124
This slide serves as a transition or section header for a highly critical argument against the company.name_villain
125
The slide uses a legal statute to frame the company's business model as criminal activity.name_villain
126
The slide uses a narrative structure to explain a systemic loophole, supported by a direct excerpt from an official policy document.expose_contradiction
127
The slide uses a combination of narrative summary and direct excerpts from a Feb 2024 letter to expose flaws in the OPTN allocation system.expose_contradiction
128
The slide presents anecdotal evidence of systemic gaming of the organ allocation system.expose_contradiction
129
The slide uses a direct quote from a transplant surgeon to allege systemic gaming of the organ allocation system.expose_contradiction
130
Includes direct quotes from a transplant hepatologist at Mass General Hospital to support the thesis of perverse incentives.name_villain
131
The slide uses a Q&A transcript format to highlight a competitor's critique of the subject company's business model.expose_contradiction
132
The slide uses a 'villain' narrative framing, comparing the medical system to a cartel and highlighting the 'addiction to volume' as a driver for TransMedics seillustrate_case
133
The slide presents a narrative of systemic corruption and regulatory bypass involving TransMedics and OPOs.expose_contradiction
134
The slide uses a Q&A format to document expert testimony regarding potential kickbacks and regulatory circumvention.expose_contradiction
135
The slide uses a Q&A format to highlight alleged unethical business practices.expose_contradiction
136
The slide uses highlighted quotes from transplant surgeons to build a case for potential regulatory or ethical issues regarding TransMedics' business practices.expose_contradiction
137
The slide uses a Q&A format to highlight a specific allegation of unethical business practices.expose_contradiction
138
The slide presents a Q&A format with a surgeon, highlighting allegations of unethical business practices and operational friction.name_villain
139
The slide uses a Q&A format to present testimonial evidence of alleged misconduct.name_villain
140
The slide uses a Q&A format to provide direct evidence of unethical behavior in the organ transplant system.expose_contradiction
141
The slide uses a Q&A format to highlight alleged procedural violations. The yellow highlighting emphasizes the specific claims of bypassing the OPO.expose_contradiction
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.expose_contradiction
143
The slide uses a 'smoking gun' narrative to frame the testimonial as evidence of unethical business practices.expose_contradiction
144
Includes a Q&A transcript excerpt as evidence for the allegations.expose_contradiction
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.expose_contradiction
146
The slide uses a Q&A format to highlight potential regulatory violations by TransMedics.expose_contradiction
147
The slide uses a combination of summary text and a direct quote from a high-volume user to substantiate the claim of unethical organ allocation practices.expose_contradiction
148
The slide uses a Q&A format to highlight alleged unethical business practices.expose_contradiction
149
The slide uses screenshots of the UNOS/UNet portal to establish the system's official status and legal warnings.expose_contradiction
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.expose_contradiction
151
The slide presents two Q&A excerpts from a transplant surgeon to support the claim that TransMedics is hijacking the organ allocation process.expose_contradiction
152
The slide uses direct quotes from industry experts to build a case against TransMedics' business practices.expose_contradiction
153
The slide uses a Q&A format to highlight potential misuse of system access.expose_contradiction
154
Includes a direct quote from an unnamed source regarding the company's technicians.name_villain
155
The slide uses a 'fraud-exposure' framework to contrast alleged real-world usage with official FDA labeling.expose_contradiction
156
The slide uses a combination of qualitative expert interview summaries and quantitative data from the company's own investor presentation to frame the company'sexpose_contradiction
157
The slide uses a testimonial to undermine the corporate narrative of 'Game Changer' technology, suggesting it is instead a tool for labor convenience.expose_contradiction
158
The slide uses a testimonial/interview format to challenge the necessity of the OCS device for local transplants.expose_contradiction
159
The slide uses Q&A transcripts to undermine a business model premise.expose_contradiction
160
The slide uses direct quotes from transplant directors to challenge the value proposition of TransMedics' NOP service.expose_contradiction
161
The slide uses a Q&A format to substantiate the claim of reckless off-label usage.name_villain
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.expose_contradiction
163
The slide uses direct quotes to expose a misalignment between the stated value proposition (reduced hospitalization) and the actual usage (scheduling conveniencexpose_contradiction
164
The slide uses a primary headline followed by a detailed supporting quote, highlighting the ethical and financial concerns regarding off-label use of perfusion expose_contradiction
165
The slide uses a Q&A format to present a negative testimonial/critique of the company's sales tactics.name_villain
166
The slide uses direct quotes from UCSF hospital administrators to frame the argument that TransMedics usage is being curtailed due to cost and lack of clinical expose_contradiction
167
Uses direct quotes from surgeons at Utah and UCSD to support the thesis of off-label, convenience-driven usage.expose_contradiction
168
The slide uses direct quotes to highlight a discrepancy between the purported clinical value of the device and the actual operational use case.expose_contradiction
169
The slide uses direct quotes from anonymous experts to build a case of 'expensive abuse' of medical technology.expose_contradiction
170
The slide uses a Q&A transcript format to build a case against the clinical justification of the product's usage.expose_contradiction
171
The slide uses expert quotes to frame 'back to base' usage as a potentially harmful, off-label practice driven by convenience rather than clinical necessity.expose_contradiction
172
The slide uses a Q&A format to highlight a specific industry pain point regarding the misuse of medical technology.expose_contradiction
173
The slide highlights a specific operational failure (delayed pump usage) causing a 10% loss rate in the region.expose_contradiction
174
The slide contrasts the author's claims of widespread off-label use with the official FDA 'Indications for Use' text.expose_contradiction
175
The slide uses a 'villain_critique' approach by quoting an ex-employee to expose what the author considers to be fraudulent medical claims.expose_contradiction
176
The slide uses a table from a JAMA Surgery paper to highlight the mean donor age in the trial (45.9 years) as evidence of selection bias.expose_contradiction
177
Includes a Q&A transcript excerpt highlighting the risks of off-label use beyond the 30-minute window.preempt_rebuttal
178
The slide uses expert quotes to argue that off-label use of perfusion pumps is limited by reputational risk and biological constraints.preempt_rebuttal
179
The slide uses a Q&A transcript format to highlight the discrepancy between regulatory guidelines and real-world surgical behavior.expose_contradiction
180
The slide uses a specific study to challenge the safety/efficacy claims of machine perfusion vendors like TransMedics.expose_contradiction
181
The slide uses a combination of narrative summary and verbatim Q&A transcripts to highlight discrepancies between trial conditions and real-world usage.expose_contradiction
182
The slide uses excerpts from clinical literature to define the risks of transplanting steatotic livers.establish_context
183
The slide uses direct quotes from a transplant surgeon to expose potential malpractice or dangerous usage patterns.expose_contradiction
184
The slide uses a Q&A transcript format to frame the company's business model as 'quackery' and reliant on 'marginal' organs.expose_contradiction
185
The slide uses a 'villain' narrative style to frame the company's business practices as risky or non-compliant.expose_contradiction
186
The slide uses expert testimony to challenge the value proposition of the TransMedics technology.expose_contradiction
187
The slide uses a direct quote from a surgeon to highlight a perceived contradiction in the company's marketing claims.expose_contradiction
188
The slide uses a Q&A format to expose that the device is being used for high-risk, 'reckless' practices rather than standard clinical indications.expose_contradiction
189
The slide uses a Q&A transcript format to substantiate claims of fraud and kickbacks.expose_contradiction
190
The slide uses a Q&A format to highlight a specific allegation of unethical pressure to over-utilize a medical device.expose_contradiction
191
The slide uses expert testimony to contradict the manufacturer's regulatory compliance claims.expose_contradiction
192
The slide uses a Q&A transcript format to build a case against the company's stated compliance.expose_contradiction
193
This slide serves as a transition or section header for a specific critique point.diagnose_problem
194
The slide uses direct quotes from a former executive to highlight perceived operational failures and poor talent quality at TransMedics.expose_contradiction
195
The slide uses a combination of summary text and a direct pull-quote with highlighted text to emphasize the severity of the claims.name_villain
196
The slide uses direct quotes from a transplant surgeon to validate the claim of incompetence and poor operational performance.expose_contradiction
197
The slide uses a Q&A format to highlight specific allegations of surgical incompetence and device-related risks.expose_contradiction
198
The slide uses a Q&A format to present a negative expert opinion on TransMedics' clinical quality and hiring standards.expose_contradiction
199
The slide uses a Q&A format to present qualitative evidence of operational failures and reputational damage.name_villain
200
The slide uses Q&A format to present qualitative evidence of operational failure.expose_contradiction
201
The slide uses a Q&A format to build a narrative of malpractice and dishonesty.expose_contradiction
202
The slide uses direct quotes to highlight negative perceptions of TransMedics' hiring practices and surgeon qualifications.expose_contradiction
203
The slide uses a Q&A format to present qualitative feedback from an industry expert.expose_contradiction
204
The slide uses direct quotes to frame the subject as a villain/incompetent actor. It is a classic 'expert testimony' attack.name_villain
205
The slide uses direct quotes from an organ procurement technician to build a case against NOP surgeons' technical proficiency.expose_contradiction
206
The slide uses direct quotes and interview transcripts to build a case of professional negligence or strategic malpractice.expose_contradiction
207
The slide uses direct quotes to frame TransMedics' surgical practices as a liability and a regression in quality standards.expose_contradiction
208
The slide uses a 'villain' narrative structure to cast doubt on the company's operational standards.expose_contradiction
209
The slide uses direct quotes to expose a gap between customer perception and the company's actual practices.expose_contradiction
210
The slide uses direct quotes from a former employee to build a case against the company's operational integrity.expose_contradiction
211
The slide uses a Q&A format to highlight the 'unusual' nature of the credentialing process, followed by a direct citation of the AOPO manual to suggest a violatexpose_contradiction
212
The slide uses a Q&A format to substantiate claims of regulatory circumvention.expose_contradiction
213
The slide uses a Q&A format to present expert testimony regarding TransMedics' NOP (National Organ Procurement) operations.expose_contradiction
214
This is a highly aggressive, investigative-style slide typical of short-seller research reports.name_villain
215
The slide uses a red arrow to connect a LinkedIn profile to a physical facility in Trinidad/Tobago to highlight the surgeon's dual employment.expose_contradiction
216
The slide uses a 'villain' or 'exposing' framing to cast doubt on the company's hiring practices.expose_contradiction
217
The slide uses screenshots of tweets to document the surgeon's use of derogatory language, which is highlighted with red boxes.expose_contradiction
218
The slide uses screenshots of social media posts to establish a pattern of behavior.expose_contradiction
219
This is a classic activist short-seller slide focusing on management/key personnel red flags.expose_contradiction
220
The slide uses screenshots of a LinkedIn profile and a scientific paper to establish a connection between the subject and specific companies.expose_contradiction
221
The slide uses visual evidence from the Internet Archive to contradict the company's attempt to distance itself from Macchiarini.expose_contradiction
222
The slide uses external media references (Netflix, news headlines) to establish the severity of the fraud.expose_contradiction
223
The slide uses visual evidence (red boxes and arrows) to link a specific surgeon's LinkedIn profile to news articles about organ trafficking.expose_contradiction
224
Uses juxtaposition of a news headline about arrests and a photo of a surgeon receiving a national award to highlight the contradiction.expose_contradiction
225
The slide uses screenshots as evidence to link a medical professional to a controversial third-party platform.expose_contradiction
226
The slide uses a combination of LinkedIn profile screenshots and a news headline to build a case of guilt by association.expose_contradiction
227
This slide serves as a specific accusation or 'villain' critique within a research note.name_villain
228
The slide uses a Q&A format to highlight alleged unethical practices regarding organ safety and corporate pressure.name_villain
229
The slide uses a Q&A format to highlight a perceived ethical conflict between corporate procurement goals and clinical safety standards.expose_contradiction
230
The slide uses a Q&A format to highlight the alleged restriction of professional judgment.expose_contradiction
231
The slide uses a Q&A format to highlight a breakdown in the standard organ procurement process.name_villain
232
The slide uses a Q&A format to highlight a potential conflict of interest or operational risk regarding TransMedics' NOP service.expose_contradiction
233
The slide uses testimonials from an OrganOx employee and a transplant cardiologist to argue that TransMedics' model strips control from hospitals and relies on expose_contradiction
234
The slide uses a Q&A format to substantiate claims of surgical incompetence and unethical organ distribution practices.expose_contradiction
235
The slide uses a Q&A format to highlight potential ethical concerns regarding data transparency in organ recovery.expose_contradiction
236
The slide uses a Q&A transcript format to support the primary allegation of unethical organ procurement practices.expose_contradiction
237
The slide uses a quote-heavy structure to build a narrative of corporate negligence regarding medical standards.expose_contradiction
238
The slide uses direct quotes from former employees to support the claim of incompetence and lack of proper medical oversight.expose_contradiction
239
The slide uses direct quotes to build a narrative of negligence and poor surgical technique.name_villain
241
The slide uses a quote from Congressman Paul Gosar to substantiate claims of a 'bait and switch' business model.name_villain
242
The slide uses a quote-based argument to challenge the company's stated quality control rationale.expose_contradiction
243
The slide uses direct quotes to highlight operational failures and lack of training in the field.expose_contradiction
244
The slide uses a narrative structure to expose operational risks and employee dissatisfaction.diagnose_problem
245
The slide uses a Q&A format to highlight alleged safety violations and hospital staff complaints.expose_contradiction
246
The slide uses a narrative format to expose operational failures and potential ethical/regulatory concerns regarding TransMedics' high-volume users.name_villain
247
The slide uses direct quotes to highlight operational risks and potential regulatory/ethical violations regarding the use of OCS specialists.expose_contradiction
248
The slide uses a Q&A transcript format to substantiate claims of poor management and safety negligence.expose_contradiction
250
The slide uses strong, emotive language to frame the company's leadership as the primary antagonist.name_villain
251
The slide uses highlighted text to emphasize key grievances (dishonesty, forced bundling, anger).name_villain
252
The slide uses direct quotes from KOLs to build a negative narrative around the company's business ethics.expose_contradiction
253
The slide uses highlighted text to emphasize key quotes from former executives regarding the CEO's professional conduct.name_villain
254
The slide uses direct quotes from former employees and industry contacts to build a negative narrative around the CEO's personality and professional standing.name_villain
255
The slide uses a combination of summary text and a direct quote to highlight unethical business practices.expose_contradiction
256
The slide uses a Q&A transcript format to substantiate a serious allegation of unethical business practices.expose_contradiction
257
The slide uses verbatim interview transcripts to substantiate claims of extortion and unprofessional conduct by specific named executives.name_villain
258
The slide uses a Q&A transcript format to highlight negative sentiment regarding company culture and sales practices.expose_contradiction
259
The slide uses a Q&A format to document allegations of unethical sales pressure by a specific individual (Magdy Attia) at TransMedics.expose_contradiction
260
The slide uses a Q&A format to build a case against the company's business practices.expose_contradiction
261
The slide uses a Q&A format to highlight potential malpractice and coercion.expose_contradiction
262
The slide presents a narrative of a specific medical failure involving a necrotic liver, alleging that TransMedics may be concealing damage from receiving centeexpose_contradiction
263
The slide uses a Q&A format to highlight a specific allegation of corporate dishonesty.expose_contradiction
264
The slide uses a Q&A format to highlight a perceived cover-up by the company regarding device performance.expose_contradiction
265
The slide uses a quote to highlight a perceived lack of transparency by the company.expose_contradiction
266
The slide uses direct quotes to characterize the CEO as 'arrogant' and the company's behavior as 'extortion' and 'aggressive'.name_villain
267
The slide uses a combination of summary text and direct interview transcripts to build a case of corporate misconduct.expose_contradiction
268
The slide presents a narrative of professional misconduct and coercion within an organ procurement organization.expose_contradiction
269
This appears to be a narrative slide from a research note or report, focusing on churn.diagnose_problem
270
The slide uses anecdotal evidence from a 'prominent surgeon' to support a bearish thesis on TransMedics.name_villain
271
The slide uses direct quotes from surgeons to build a narrative of financial unviability and institutional pushback against the product.name_villain
272
The slide uses a Q&A format to directly contradict claims made by the TransMedics CEO regarding reimbursement pass-through.expose_contradiction
273
The slide uses direct quotes to build a narrative of customer churn and institutional resistance.name_villain
274
The slide uses Q&A transcripts to highlight a shift away from OCS technology in high-volume transplant centers.expose_contradiction
275
The slide uses a 'villain critique' style to highlight negative sentiment from industry insiders regarding TransMedics.expose_contradiction
276
The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.expose_contradiction
277
The slide uses direct quotes from a high-volume TransMedics user to illustrate market vulnerability and the shift toward competitors offering more autonomy.expose_contradiction
278
The slide uses a Q&A format to build a narrative of market abandonment.expose_contradiction
279
The slide uses direct quotes from an UCSF administrator to build a case against TransMedics' long-term viability at the institution.expose_contradiction
280
The slide uses highlighted text to emphasize key negative sentiment regarding TransMedics' sustainability and market position.preempt_rebuttal
281
This slide serves as a highly critical, accusatory statement against the subject company.name_villain
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.name_villain
283
The slide uses direct quotes from KOLs to frame the company's technology as a commoditized, overpriced solution with no clinical advantage over traditional coldname_villain
284
The slide uses direct quotes from a KOL to undermine the company's market position.expose_contradiction
285
The slide uses a 'villain critique' approach by aggregating expert opinions to undermine the company's value proposition.expose_contradiction
286
The slide uses a Q&A format to highlight the gap between the device's intended utility and real-world clinical experience.expose_contradiction
287
The slide uses highlighted text to emphasize key negative findings regarding the OCS technology's performance metrics.name_villain
288
The slide uses a 'before-after' style comparison between a conceptual timeline and actual competitor hardware.name_villain
289
The slide uses expert quotes to undermine the competitive moat of TransMedics by comparing it to existing, commoditized kidney perfusion technology.name_villain
290
The slide uses a Q&A format to highlight the perceived lack of value proposition for the OCS Lung product.expose_contradiction
291
The slide uses direct quotes from a surgeon to undermine the company's value proposition.name_villain
292
The slide uses highlighted text to emphasize key negative claims from a surgeon.expose_contradiction
293
The slide uses expert testimonials to argue that the TransMedics device is 'fatally flawed' because it does not allow for functional assessment under load.name_villain
294
The slide uses direct quotes from surgeons to validate the market share shift thesis.summarize
295
The slide uses a direct quote from a surgeon to undermine the credibility and clinical utility of the TransMedics OCS device.expose_contradiction
296
The slide uses a direct quote from an expert to undermine the value proposition of the TransMedics device.expose_contradiction
297
The slide uses a quote-heavy structure to undermine the investment thesis for TransMedics (TMDX).name_villain
298
The slide uses a Q&A transcript format to highlight negative expert sentiment.expose_contradiction
299
The slide presents a synthesis of expert commentary followed by verbatim Q&A excerpts highlighting the 'last resort' nature of the current service and the futursummarize
300
The slide uses direct quotes from surgeons and an ex-employee to build a case against the viability of the NOP service for heart transplants.preempt_rebuttal
301
The slide uses direct quotes and Q&A transcripts to undermine the clinical value proposition of the TransMedics device.expose_contradiction
302
The slide uses direct quotes to undermine the value proposition of the OCS device.expose_contradiction
303
This is a text-only slide serving as a section header or key point in a research note.name_villain
304
The slide uses direct quotes from surgeons to build a bearish case against the company (TransMedics/Waleed).name_villain
305
The slide uses a 'laundry list' format to present competitive threats, supported by product imagery.compare_peers
306
The slide uses a 'villain' narrative structure to frame TransMedics as vulnerable to upcoming competition.expose_contradiction
307
The slide uses expert testimony to build a bearish case against the incumbent (TransMedics).expose_gap
308
The slide uses expert testimony to undermine the value proposition of TransMedics' portability.name_villain
309
The slide uses direct quotes from an OrganOx employee and a leading transplant surgeon to validate the thesis.summarize
310
The slide uses direct quotes from transplant surgeons and hepatologists to validate the thesis of market disruption.illustrate_case
311
The slide highlights a competitive threat to TransMedics driven by OPO purchasing behavior.expose_contradiction
312
The slide uses direct quotes from an industry expert to build a bearish case against TransMedics.expose_contradiction
313
The slide uses a direct quote to highlight a competitive threat to TransMedics' business model.expose_contradiction
314
The slide uses direct quotes from an organ procurement specialist to validate the thesis of market disruption.illustrate_case
315
The slide uses direct quotes from a transplant surgeon to validate the thesis that TransMedics is at risk of being rendered obsolete by competitors.expose_gap
316
Includes verbatim transcripts from a transplant surgeon regarding competitive dynamics in the liver transplant market.expose_contradiction
318
The slide uses a combination of cost comparison and technical diagrams to argue for the obsolescence of the subject company's core product.expose_gap
319
The slide uses expert testimony to frame TransMedics as an overpriced incumbent being disrupted by a cheaper, established European technique (NRP).name_villain
320
The slide uses direct quotes from a consultation call to highlight the competitive threat of NRP to TransMedics.expose_contradiction
322
The slide contrasts the perceived limitations of TransMedics' technology with the functional advantages of NRP, supported by expert testimony and market evidencexpose_contradiction
323
The slide uses a 'canary in the coal mine' metaphor to frame the loss of a major customer as a leading indicator of broader market share erosion.preempt_rebuttal
324
The slide uses direct quotes from industry experts to validate the thesis of NRP market penetration.illustrate_case
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug markecite_precedent
326
This slide functions as a 'villain critique' or 'fraud exposure' note, likely part of a short-seller research report.name_villain
327
The slide uses direct quotes from former employees to build a case for corporate malfeasance and product failure.expose_contradiction
328
The slide uses a Q&A format to present testimony, highlighting specific instances of alleged misconduct.expose_contradiction
329
The slide uses a Q&A transcript format to substantiate claims about corporate governance and safety oversight failures.expose_contradiction
330
The slide uses direct quotes from former employees and industry peers to build a case against the reliability of the TransMedics OCS device.expose_contradiction
331
Includes a direct quote from a CEO of a major OPO regarding a surgeon's resignation due to safety concerns.expose_contradiction
332
The slide presents a Q&A format to highlight a specific technical failure mode (necrosis) attributed to the device's design.expose_contradiction
333
The slide uses visual evidence (images of livers and CT scans) to support the argument that machine perfusion causes lasting tissue damage.expose_contradiction
334
The slide uses a combination of narrative summary and direct Q&A excerpts to build a case against the company's product claims.name_villain
335
The slide uses a Q&A format to highlight a specific failure in the procurement process.expose_contradiction
336
The slide presents a narrative of corporate deception regarding medical device performance.expose_contradiction
337
The slide uses a Q&A format to highlight a perceived cover-up by the company.expose_contradiction
338
The slide uses a quote to highlight a perceived lack of transparency by the company.expose_contradiction
339
The slide presents a narrative of institutional failure and ethical concerns regarding medical device reporting.expose_contradiction
340
The slide uses a Q&A format to highlight a specific expert's negative experience with TransMedics equipment and corporate communication.expose_contradiction
341
The slide highlights a critical failure in safety protocols and regulatory compliance as perceived by an industry expert.expose_contradiction
342
The slide uses highlighted text to emphasize key allegations of non-reporting and unethical behavior.expose_contradiction